The TREOCAPA trial was a multicenter, phase III study involving 14 European countries. The study investigated the preventive use of paracetamol, in preterm infants (23–26 weeks of gestation), evaluating its impact on the closure of patent ductus arteriosus as well as on common complications associated with preterm birth. conect4children worked in close collaboration with the sponsor INSERM, ECRIN, and GFCNI, to support the study’s execution. In Portugal, the three participating sites were also supported by STAND4Kids...Continue Reading
This month’s newsletter highlights our activities from November 2025 to February 2026. In this edition, we share the events where STAND4Kids was present and highlight our role in Portugal Clinical Studies as a thematic network and service provider. For more information about Portugal Clinical Studies, visit: https://portugalclinicalstudies.com/ Download [HERE].Continue Reading
Hospital Pediátrico de Coimbra (ULS de Coimbra – Principal Investigator Dr. Catarina Neves) has enrolled the first national participant in the EMPA-KIDNEY Kids study. The EMPA-KIDNEY Kids study aims to assess the pharmacokinetics, safety, and efficacy of empagliflozin tablets in children and adolescents aged 2 to 17 years with chronic kidney disease. Study details are...Continue Reading
Our Highlights this month are dedicated to our activities from July to October. This edition showcases our main activities aimed at promoting high quality paediatric clinical trials. Download [HERE].Continue Reading
Ricardo Fernandes, STAND4Kids Lead, has been elected the new Chair of the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) Coordinating Group. Congratulations!Continue Reading
Our STAND4Kids team participated in the 25th National Congress of Pediatrics, which took place from October 29 to 31 in Porto. We had the opportunity to present two posters with discussion, one highlighting the work and achievements of the STAND4Kids and another presenting the project “Mapping Existing Materials on Paediatric Clinical Research in Portugal”. Our...Continue Reading
Collaboration is everything! A heartfelt thank you to Boehringer Ingelheim for inviting us to join and support the European Investigators’ Meeting. STAND4Kids is proud to be part of the launch of this exciting paediatric chronic kidney disease (CKD) study. With our team engaged, we are committed to helping Boehringer Ingelheim move swiftly through study enrollment...Continue Reading
On 26 September 2025, our team participated in European Researchers’ Night, where we shared the importance of paediatric clinical research through a variety of fun and educational activities. A special thank you to the Lisbon School of Medicine, University of Lisbon, for the opportunity to bring science closer to the community and promote scientific literacy...Continue Reading
Our Highlights this month are dedicated to our activities from March to June. This edition showcases the main activities of the STAND4Kids network during the conclusion of the conect4children (c4c) project, and looks ahead to the future of the network and the conect4children Stichting. Together, we will continue working to promote high-quality paediatric clinical trials....Continue Reading
On this special day, we celebrate and highlight the importance of empowering children through education and science. On the 23rd of April, the Literacy in Paediatric Clinical Research event was held at the Faculdade de Medicina da Universidade de Lisboa. The event also marked the opening of an exhibition showcasing projects developed by primary school...Continue Reading
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777389. The Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA